Biotoxtech Temettü

Temettü kriter kontrolleri 0/6

Biotoxtech does not have a record of paying a dividend.

Anahtar bilgiler

n/a

Temettü verimi

n/a

Geri Alım Getirisi

Toplam Hissedar Getirisi	n/a
Gelecekteki Temettü Verimi	n/a
Temettü Büyümesi	n/a
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	n/a
Ödeme oranı	n/a

Son temettü güncellemeleri

Güncelleme yok

Recent updates

Improved Revenues Required Before Biotoxtech Co., Ltd. (KOSDAQ:086040) Shares Find Their Feet

Oct 21

Are Robust Financials Driving The Recent Rally In Biotoxtech Co., Ltd.'s (KOSDAQ:086040) Stock?

Jan 24

We're Not So Sure You Should Rely on Biotoxtech's (KOSDAQ:086040) Statutory Earnings

Dec 27

Is Biotoxtech (KOSDAQ:086040) Using Too Much Debt?

Nov 30

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: Insufficient data to determine if A086040's dividends per share have been stable in the past.

Büyüyen Temettü: Insufficient data to determine if A086040's dividend payments have been increasing.

Piyasaya Karşı Temettü Getirisi

Biotoxtech Piyasaya Karşı Temettü Getirisi

A086040 temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (A086040)	n/a
Pazarın Alt %25'i (KR)	1.2%
Pazarın En İyi %25'i (KR)	3.8%
Sektör Ortalaması (Life Sciences)	1.0%
Analist tahmini (A086040) (3 yıla kadar)	n/a

Önemli Temettü: Unable to evaluate A086040's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

Yüksek Temettü: Unable to evaluate A086040's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: Insufficient data to calculate A086040's payout ratio to determine if its dividend payments are covered by earnings.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: Unable to calculate sustainability of dividends as A086040 has not reported any payouts.

Biotoxtech Temettü

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü güncellemeleri

Recent updates

Improved Revenues Required Before Biotoxtech Co., Ltd. (KOSDAQ:086040) Shares Find Their Feet

Biotoxtech Co., Ltd. (KOSDAQ:A086040) announces an Equity Buyback for KRW 1,000 million worth of its shares.

New major risk - Revenue and earnings growth

New minor risk - Shareholder dilution

No independent directors

Investor sentiment deteriorated over the past week

No independent directors

Investor sentiment improved over the past week

Biotoxtech Co., Ltd. announced that it has received KRW 18 billion in funding from BNK Securities Co., Ltd., Investment Arm, Mirae Asset Securities Co., Ltd. and other investors

Biotoxtech Co., Ltd. announced that it expects to receive KRW 18000 billion in funding from BNK Securities Co., Ltd., Investment Arm

Is Biotoxtech (KOSDAQ:086040) A Risky Investment?

Estimating The Fair Value Of Biotoxtech Co., Ltd. (KOSDAQ:086040)

Did Biotoxtech's (KOSDAQ:086040) Share Price Deserve to Gain 91%?

New 90-day low: ₩11,200

Are Robust Financials Driving The Recent Rally In Biotoxtech Co., Ltd.'s (KOSDAQ:086040) Stock?

We're Not So Sure You Should Rely on Biotoxtech's (KOSDAQ:086040) Statutory Earnings

Investor sentiment deteriorated over the past week

Is Biotoxtech (KOSDAQ:086040) Using Too Much Debt?

Market bids up stock over the past week

New 90-day high: ₩16,050

New 90-day high: ₩14,200

New 90-day high - ₩13,050

New 90-day high - ₩12,000

Ödemelerde İstikrar ve Büyüme

Piyasaya Karşı Temettü Getirisi

Hissedarlara Ödenen Kazanç

Hissedarlara Nakit Ödeme

Güçlü temettü ödeyen şirketleri keşfedin